Return
Effectiveness of the AI-TCT Combined with HPV-cPAS Strategy in Cervical Cancer Screening: A Comparison with TCT Alone
X
W
X
I
W
P
Z
DOI:10.1016/j.annepidem.2026.110162.png)
Abstract
En 中文
To compare the real-world performance of combined screening using Artificial Intelligence-assisted ThinPrep Cytologic Test (AI-TCT) and human papillomavirus combined probe anchored polymerization sequencing (HPV-cPAS) versus TCT alone for cervical cancer screening, and to evaluate the application value of the combined screening strategy in a real-world population.
Journal
IF:
3
Papers:
3.7K
Citations:
8.1K
